RxDoctor Payments Data

Katharine Nicholson

Neurology · Boston, MANPI 1033343256

Payments from drug & device makers

$418,584in general payments, 2019–2025

Across 21 payments — averaging $19,933 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$311K
  • Orphai Therapeutics Inc.$101K
  • Avanir Pharmaceuticals, Inc.$4K
  • Tanabe Pharma America, Inc.$2K
  • Mitsubishi Tanabe Pharma Development America, Inc.$697
  • Regeneron$500
$605in research payments, 2019–2025

Across 1 payment — averaging $604.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$605

What the payments were for

  • Consulting fees$10,39193%
  • Travel & lodging$6456%
  • Food & beverage$1581%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$418,584 in reported general payments places this provider in the 90th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Other neurology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →